- Home
- APVO vs VEEE Comparison
APVO vs VEEE Comparison
Compare APVO & VEEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APVO
- VEEE
- Stock Information
- Founded
- APVO 2016
- VEEE 1994
- Country
- APVO United States
- VEEE United States
- Employees
- APVO N/A
- VEEE N/A
- Industry
- APVO Biotechnology: Pharmaceutical Preparations
- VEEE Marine Transportation
- Sector
- APVO Health Care
- VEEE Industrials
- Exchange
- APVO Nasdaq
- VEEE Nasdaq
- Market Cap
- APVO 4.9M
- VEEE 5.8M
- IPO Year
- APVO N/A
- VEEE 2021
- Fundamental
- Price
- APVO $1.57
- VEEE $2.38
- Analyst Decision
- APVO Strong Buy
- VEEE
- Analyst Count
- APVO 1
- VEEE 0
- Target Price
- APVO $5,920.00
- VEEE N/A
- AVG Volume (30 Days)
- APVO 176.9K
- VEEE 4.4M
- Earning Date
- APVO 11-06-2025
- VEEE 11-13-2025
- Dividend Yield
- APVO N/A
- VEEE N/A
- EPS Growth
- APVO N/A
- VEEE N/A
- EPS
- APVO N/A
- VEEE N/A
- Revenue
- APVO N/A
- VEEE $13,153,262.00
- Revenue This Year
- APVO N/A
- VEEE N/A
- Revenue Next Year
- APVO N/A
- VEEE N/A
- P/E Ratio
- APVO N/A
- VEEE N/A
- Revenue Growth
- APVO N/A
- VEEE N/A
- 52 Week Low
- APVO $1.41
- VEEE $1.86
- 52 Week High
- APVO $381.10
- VEEE $9.30
- Technical
- Relative Strength Index (RSI)
- APVO 47.04
- VEEE 53.52
- Support Level
- APVO N/A
- VEEE $2.31
- Resistance Level
- APVO $1.54
- VEEE $2.62
- Average True Range (ATR)
- APVO 0.18
- VEEE 0.32
- MACD
- APVO -0.02
- VEEE 0.03
- Stochastic Oscillator
- APVO 57.55
- VEEE 32.50
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
About VEEE Twin Vee PowerCats Co.
Twin Vee PowerCats Co is a designer, manufacturer, and marketer of recreational and commercial power boats to use for fishing, diving and water skiing, and commercial activities including transportation, eco-tours, fishing, and diving expeditions. The company offers various boat models, including Twin Vee 400 GFX2 CC, Twin Vee 280 GFX2 CC, and Twin Vee 260 Center Console STX, among others. Its products are marketed under two brands, Twin Vee for its catamarans, or dual-hull vessels, and Aquasport for its V-hull boats. The company sells its boats through a network of independent boat dealers across North America, the Caribbean, and Central America who resell the boats to the end user, Twin Vee customers.